Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Mallinckrodt
Express Scripts
Baxter
Medtronic

Last Updated: December 6, 2019

DrugPatentWatch Database Preview

Details for Biologics License Application: 125166

See Plans and Pricing

« Back to Dashboard

Summary for BLA: 125166
Tradename:SOLIRIS
Applicant:Alexion Pharm
Ingredient:eculizumab
Patents:75
Approval Date:Mar 16, 2007
Suppliers: see list1
Pharmacology for BLA: 125166
Drug ClassComplement Inhibitor
Mechanism of ActionComplement Inhibitors

US Patents for BLA: 125166

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Alexion Pharm SOLIRIS eculizumab INJECTABLE; IV (INFUSION) 125166 001 2007-03-16   Start Trial CureVac AG (Tubingen, DE) 2032-02-15 RX Orphan search
Alexion Pharm SOLIRIS eculizumab INJECTABLE; IV (INFUSION) 125166 001 2007-03-16   Start Trial Genelux Corporation (San Diego, CA) 2034-01-02 RX Orphan search
Alexion Pharm SOLIRIS eculizumab INJECTABLE; IV (INFUSION) 125166 001 2007-03-16   Start Trial Alexion Pharmaceuticals, Inc. (Boston, MA) 2029-11-05 RX Orphan search
Alexion Pharm SOLIRIS eculizumab INJECTABLE; IV (INFUSION) 125166 001 2007-03-16   Start Trial CytomX Therapeutics, Inc. (South San Francisco, CA) 2033-01-04 RX Orphan search
Alexion Pharm SOLIRIS eculizumab INJECTABLE; IV (INFUSION) 125166 001 2007-03-16   Start Trial SHIRE VIROPHARMA INCORPORATED (Lexington, MA) 2039-05-17 RX Orphan search
Alexion Pharm SOLIRIS eculizumab INJECTABLE; IV (INFUSION) 125166 001 2007-03-16   Start Trial Glycotope GmbH (Berlin, DE) 2026-09-10 RX Orphan search
Alexion Pharm SOLIRIS eculizumab INJECTABLE; IV (INFUSION) 125166 001 2007-03-16   Start Trial CMC BIOLOGICS A/S (Soborg, DK) 2033-03-19 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
Harvard Business School
McKesson
McKinsey
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.